A groundbreaking study has been initiated to explore the connections between myalgic encephalomyelitis (ME), commonly known as chronic fatigue syndrome (CFS), and Long Covid, providing a glimmer of hope for the millions impacted by these debilitating conditions. Funded by the ME Association and conducted at Imperial College London, the £1.1 million Rosetta Stone study aims to investigate the immunological profiles and potential biomarkers shared between the two illnesses.
The Heartbreaking Reality for Families
Harbinder, a mother from Redbridge, has seen her children’s once-promising futures turn into a daily struggle due to their health conditions. All three of her children have been diagnosed with ME, while her son Talvin is also suffering from Long Covid following three separate infections with the virus. The family now faces overwhelming fatigue, sleep disturbances, and cognitive difficulties, which have drastically changed their lives.
“My eldest daughter, who’s now 15, was academically gifted and an avid athlete,” Harbinder shared. “Now, they essentially have learning difficulties. They struggle to remember words, finish sentences, and comprehend texts.”
Despite the challenges, Harbinder remains optimistic about the upcoming research, which is expected to shed light on the links between Long Covid and ME, conditions estimated to affect around 1.3 million individuals in the UK.
Lives Interrupted
The impact of these illnesses extends beyond physical limitations. Harbinder describes how her once active family has been forced to abandon outdoor activities and travel. “We used to enjoy camping and skiing together. Now, life looks very different,” she lamented.
Her eldest daughter, Simrun, faces additional health challenges due to Postural Orthostatic Tachycardia Syndrome (PoTS), which causes her to faint upon standing. Simrun’s symptoms include joint pain, nausea, and constant fatigue. Talvin, who was previously a vibrant child, now endures daily headaches that prevent him from engaging in normal activities.
“The education system has not adapted to their needs,” Harbinder noted. “We are navigating this journey without a clear path.”
A Call for Research and Understanding
Tim Goodwyn, 37, from Bury St Edmunds, is another individual grappling with the realities of Long Covid. After contracting a virus in November 2023, he has found himself largely bedridden, unable to perform even basic daily tasks without assistance. “I wish I could go out and have adventures with my family, but I’m confined to my home,” he expressed.
Tim’s experience reflects a broader pattern of underfunding in research for ME and Long Covid. However, he remains hopeful that the new study will contribute to a better understanding of these complex conditions. “This research might not find a cure immediately, but it could definitely bring us closer to understanding these illnesses,” he said.
The Rosetta Stone study will involve the analysis of blood, stool, and saliva samples from 250 participants diagnosed with ME, 250 with Long Covid, and matched healthy controls. This comprehensive approach aims to identify shared molecular pathways that may explain the persistent symptoms experienced by those affected.
Experts Weigh In
Dr Charles Shepherd, honorary medical adviser at The ME Association, remarked on the growing recognition of the similarities between Long Covid and ME. “A significant number of Long Covid patients meet the criteria for ME. It took time for the medical community to acknowledge that these are overlapping conditions,” he explained.
Prof Danny Altmann from Imperial College highlighted the urgent need for research into these persistent health issues. “Millions of lives have been disrupted by the disabilities caused by Long Covid and ME/CFS. Our goal is to uncover the underlying mechanisms and inform future therapeutic developments,” he stated.
Dr Rae Duncan, a consultant cardiologist and Long Covid expert, emphasised that while ME and Long Covid are distinct, they share debilitating effects on patients’ lives. “We urgently need increased funding to match the level of need and disability,” she insisted, calling the new study “a brilliant initiative.”
Why it Matters
The launch of the Rosetta Stone study represents a significant step forward in understanding the complex interplay between ME and Long Covid. As research efforts expand, there is hope for improved diagnostics, treatments, and ultimately, better lives for those affected by these challenging conditions. The families affected are not just statistics; they are individuals with dreams, aspirations, and the right to a healthier future.
